Efficacy and Mechanism Evaluation programme - Logo

Researcher-led worksteam collaboration with Industry

Quicklinks
 New funding stream for translational medicine
 Apply for Funding
The next cut off date for the researcher-led workstream is 1pm Friday 9 March 2012. The next cut off for the commissioned workstream is 1pm Monday 13 February 2012

 Get Involved
Find out how to get involved with our work
 Resources
Useful links and information to help with applications
 Join our mailing list
Latest News
 Detecting fetal abnormalities in pregnancy

NETSCC publishes a pilot evaluation of the draft MHRA risk-adapted approaches guidance

 Effectiveness of antibiotic drug in asthma attacks
 Behavioural therapy for treatment resistant depression
rss EME News Feed
twitter icon Follow NIHR on Twitter
 

 

Valid XHTML 1.0 Transitional

 

Plain English Campaign

 you are here › Home Researcher-led collaboration with Industry

The EME researcher-led worksteam will support studies involving partnerships with industry where these are for public benefit, and are not for the exclusive benefit of the industry partner. Where your research proposal involves industry collaboration, you should ensure the arrangements and details are determined early in the study development, and that relevant agreements are in place at the outset of the project. The EME researcher-led worksteam will require assurance that any industry collaboration allows transparency in the project design and in the analysis and publication of results (including if these are negative). You should also consider issues such as: relative responsibilities, governance arrangements, regulatory approvals, indemnity, intellectual property rights, reporting, and access to data and samples. Any award is conditional upon the EME researcher-led worksteam receiving a fully signed collaborative agreement between the partners in advance of the project starting.

The responsibility for ensuring that appropriate management arrangements are established for any intellectual property (IP) arising from EME researcher-led worksteam funded research rests with the host research organisation. It is responsible for negotiating and agreeing appropriate IP rights with industrial collaborators. The principles of any IP rights to be agreed with collaborators should be specified in your full proposal, to be considered by the EME Board.

If the collaboration involves the supply of reagents, drugs or other technologies, the EME researcher-led worksteam will require written assurances that the industry collaborator will provide these products for the duration of the study.

Please also read Researcher-led collaboration with charities and other funders.

 printer friendly version   share Share

The Efficacy and Mechanism Evaluation programme is funded by the MRC and NIHR, with contributions from the CSO in Scotland and NISCHR in Wales and the HSC R&D, Public Health Agency in Northern Ireland. It is managed by the NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC) based at the University of Southampton.

University of Southampton - Logo